During the last session, Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares were 0.67 million, with the beta value of the company hitting -3.41. At the end of the trading day, the stock’s price was $41.14, reflecting an intraday loss of -0.02% or -$0.01. The 52-week high for the GPCR share is $75.02, that puts it down -82.35 from that peak though still a striking 35.32% gain since the share price plummeted to a 52-week low of $26.61. The company’s market capitalization is $2.35B, and the average intraday trading volume over the past 10 days was 0.62 million shares, and the average trade volume was 663.50K shares over the past three months.
Structure Therapeutics Inc ADR (GPCR) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. GPCR has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.19.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Structure Therapeutics Inc ADR (NASDAQ:GPCR) trade information
Structure Therapeutics Inc ADR (GPCR) registered a -0.02% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -0.02% in intraday trading to $41.14, hitting a weekly high. The stock’s 5-day price performance is 9.44%, and it has moved by -2.72% in 30 days. Based on these gigs, the overall price performance for the year is -44.31%. The short interest in Structure Therapeutics Inc ADR (NASDAQ:GPCR) is 10.8 million shares and it means that shorts have 14.27 day(s) to cover.
The consensus price target of analysts on Wall Street is $93, which implies an increase of 55.76% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $65 and $118 respectively. As a result, GPCR is trading at a discount of -186.83% off the target high and -58.0% off the low.
Structure Therapeutics Inc ADR (GPCR) estimates and forecasts
Statistics show that Structure Therapeutics Inc ADR has underperformed its competitors in share price, compared to the industry in which it operates. Structure Therapeutics Inc ADR (GPCR) shares have gone up 4.71% during the last six months, with a year-to-date growth rate less than the industry average at 2.47% against 17.10. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 69.40% this quarter and then jump 68.20% in the quarter after that.
While earnings are projected to return 5.40% in 2024.
GPCR Dividends
Structure Therapeutics Inc ADR is due to release its next quarterly earnings on 2024-Aug-08. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s Major holders
Structure Therapeutics Inc ADR insiders own 4.84% of total outstanding shares while institutional holders control 106.82%, with the float percentage being 112.26%.
